Biscayne Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops therapies based on growth hormone-releasing hormone (GHRH) analogs. The compounds include GHRH antagonists in development for the treatment of cancer, including castrate-resistant prostate cancer, and GHRH agonists for the repair of cardiac damage in heart diseasepatients. The company was incorporated in 2012 and is headquartered in Miami, Florida.

Biotechnology

Pharmaceutical

Therapeutics

Biscayne Pharmaceuticals

Biscayne Pharmaceuticals' headquarters in Miami, FL, United States

Description

People

Jobs